BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 30904913)

  • 1. Common Infections and Target Organs Associated with Chronic Granulomatous Disease in Iran.
    Mortaz E; Azempour E; Mansouri D; Tabarsi P; Ghazi M; Koenderman L; Roos D; Adcock IM
    Int Arch Allergy Immunol; 2019; 179(1):62-73. PubMed ID: 30904913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Clinical Aspects of Chronic Granulomatous Disease in Upper Egypt".
    El-Mokhtar MA; Salama EH; Fahmy EM; Mohamed ME
    Immunol Invest; 2021 Feb; 50(2-3):139-151. PubMed ID: 31965875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features of chronic granulomatous disease].
    Ying WJ; Wang XC; Sun JQ; Liu DR; Yu YH; Wang JY
    Zhonghua Er Ke Za Zhi; 2012 May; 50(5):380-5. PubMed ID: 22883043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic granulomatous disease in Morocco: genetic, immunological, and clinical features of 12 patients from 10 kindreds.
    Baba LA; Ailal F; El Hafidi N; Hubeau M; Jabot-Hanin F; Benajiba N; Aadam Z; Conti F; Deswarte C; Jeddane L; Aglaguel A; El Maataoui O; Tissent A; Mahraoui C; Najib J; Martinez-Barricarte R; Abel L; Habti N; Saile R; Casanova JL; Bustamante J; Salih Alj H; Bousfiha AA
    J Clin Immunol; 2014 May; 34(4):452-8. PubMed ID: 24596025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections associated with chronic granulomatous disease: linking genetics to phenotypic expression.
    Ben-Ari J; Wolach O; Gavrieli R; Wolach B
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):881-94. PubMed ID: 23030328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The X+ chronic granulomatous disease as a fabulous model to study the NADPH oxidase complex activation].
    Stasia MJ
    Med Sci (Paris); 2007 May; 23(5):526-32. PubMed ID: 17502070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mutations in CYBB Gene Cause X-linked chronic Granulomatous Disease in Pakistani patients.
    Gul I; Khan TA; Akbar NU; Gul N; Ali R; Khan SN
    Ital J Pediatr; 2023 Aug; 49(1):95. PubMed ID: 37533075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Characteristics, Infectious, and Noninfectious Manifestations of 32 Patients with Chronic Granulomatous Disease.
    Aygun D; Koker MY; Nepesov S; Koker N; van Leeuwen K; de Boer M; Kıykım A; Ozsoy S; Cokugras H; Kuijpers T; Roos D; Camcıoglu Y
    Int Arch Allergy Immunol; 2020; 181(7):540-550. PubMed ID: 32512560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The search for a genetic defect in Polish patients with chronic granulomatous disease.
    Jurkowska M; Kurenko-Deptuch M; Bal J; Roos D
    Arch Immunol Ther Exp (Warsz); 2004; 52(6):441-6. PubMed ID: 15577746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and molecular findings of chronic granulomatous disease in Oman: family studies.
    Al-Zadjali S; Al-Tamemi S; Elnour I; AlKindi S; Lapoumeroulie C; Al-Maamari S; Pathare A; Dennison D; Krishnamoorthy R
    Clin Genet; 2015 Feb; 87(2):185-9. PubMed ID: 24446915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular diagnosis of chronic granulomatous disease.
    Roos D; de Boer M
    Clin Exp Immunol; 2014 Feb; 175(2):139-49. PubMed ID: 24016250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis of chronic granulomatous disease.
    Meischl C; Roos D
    Springer Semin Immunopathol; 1998; 19(4):417-34. PubMed ID: 9618766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungal infection and increased mortality in patients with chronic granulomatous disease.
    Bassiri-Jahromi S; Doostkam A
    J Mycol Med; 2012 Mar; 22(1):52-7. PubMed ID: 23177814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiological profile in chronic granulomatous disease patients in a single Brazilian primary immunodeficiency center.
    Oliveira AFB; Pastorino AC; Dorna MB; Castro APBM; Pegler JRM; Morgenstern B; Carneiro-Sampaio MMS
    Allergol Immunopathol (Madr); 2021; 49(2):217-224. PubMed ID: 33641311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic, Immunological, and Clinical Features of the First Mexican Cohort of Patients with Chronic Granulomatous Disease.
    Blancas-Galicia L; Santos-Chávez E; Deswarte C; Mignac Q; Medina-Vera I; León-Lara X; Roynard M; Scheffler-Mendoza SC; Rioja-Valencia R; Alvirde-Ayala A; Lugo Reyes SO; Staines-Boone T; García-Campos J; Saucedo-Ramírez OJ; Del-Río Navarro BE; Zamora-Chávez A; López-Larios A; García-Pavón-Osorio S; Melgoza-Arcos E; Canseco-Raymundo MR; Mogica-Martínez D; Venancio-Hernández M; Pacheco-Rosas D; Pedraza-Sánchez S; Guevara-Cruz M; Saracho-Weber F; Gámez-González B; Wakida-Kuzunoki G; Morán-Mendoza AR; Macías-Robles AP; Ramírez-Rivera R; Vargas-Camaño E; Zarate-Hernández C; Gómez-Tello H; Ramírez-Sánchez E; Ruíz-Hernández F; Ramos-López D; Acuña-Martínez H; García-Cruz ML; Román-Jiménez MG; González-Villarreal MG; Álvarez-Cardona A; Llamas-Guillén BA; Cuellar-Rodríguez J; Olaya-Vargas A; Ramírez-Uribe N; Boisson-Dupuis S; Casanova JL; Espinosa-Rosales FJ; Serafín-López J; Yamazaki-Nakashimada M; Espinosa-Padilla S; Bustamante J
    J Clin Immunol; 2020 Apr; 40(3):475-493. PubMed ID: 32040803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, Immunological, and Molecular Profile of Chronic Granulomatous Disease: A Multi-Centric Study of 236 Patients From India.
    Rawat A; Vignesh P; Sudhakar M; Sharma M; Suri D; Jindal A; Gupta A; Shandilya JK; Loganathan SK; Kaur G; Chawla S; Patra PK; Khadwal A; Saikia B; Minz RW; Aggarwal V; Taur P; Pandrowala A; Gowri V; Desai M; Kulkarni M; Hule G; Bargir U; Kambli P; Madkaikar M; Bhattad S; Ginigeri C; Kumar H; Jayaram A; Munirathnam D; Sivasankaran M; Raj R; Uppuluri R; Na F; George B; Lashkari HP; Kalra M; Sachdeva A; Seth S; Sabui T; Gupta A; van Leeuwen K; de Boer M; Chan KW; Imai K; Ohara O; Nonoyama S; Lau YL; Singh S
    Front Immunol; 2021; 12():625320. PubMed ID: 33717137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic granulomatous disease: six new cases.
    Martín Mateos MA; Alvaro M; Giner MT; Plaza AM; Sierra JI; Muñoz-López F
    Allergol Immunopathol (Madr); 1998; 26(5):241-9. PubMed ID: 9885732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p47phox mouse knock-out model of chronic granulomatous disease.
    Jackson SH; Gallin JI; Holland SM
    J Exp Med; 1995 Sep; 182(3):751-8. PubMed ID: 7650482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic, biochemical, and clinical features of chronic granulomatous disease.
    Segal BH; Leto TL; Gallin JI; Malech HL; Holland SM
    Medicine (Baltimore); 2000 May; 79(3):170-200. PubMed ID: 10844936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease.
    Weening RS; De Boer M; Kuijpers TW; Neefjes VM; Hack WW; Roos D
    Clin Exp Immunol; 2000 Dec; 122(3):410-7. PubMed ID: 11122248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.